Equities

Elixinol Wellness Ltd

Elixinol Wellness Ltd

Actions
  • Price (EUR)0.001
  • Today's Change-0.001 / -33.33%
  • Shares traded185.00k
  • 1 Year change-85.10%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024 07:11 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Elixinol Wellness Limited is an Australia-based hemp company. The Company is engaged in marketing and selling hemp derived and other plant-based nutraceuticals, skincare and food products. In Australia, it operates a vertically integrated business, which produces, manufactures, and distributes a range of complementary products delivered across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. These products are sold under brands including Hemp Foods Australia, Mt Elephant and Field Day and are sold through grocery, wholesale, and e-commerce channels. In the Americas, it is engaged in marketing and selling quality Elixinol branded hemp and other plant-derived nutraceutical and skincare products based in Colorado, United States. In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements.

  • Revenue in AUD (TTM)8.48m
  • Net income in AUD-7.51m
  • Incorporated2017
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EXL:ASX since
announced
Transaction
value
Ananda Food Pty LtdDeal completed12 Feb 202412 Feb 2024Deal completed-50.00%1.96m
Data delayed at least 20 minutes, as of May 08 2024 05:54 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.